These results strongly suggest that the contrasting effects of KRT19 in breast and colon cancers might be partially regulated by the differential interactions of KRT19 with β-catenin or the β-catenin/RAC1 complex, which consequently modulates NUMB-dependent Wnt/Notch signaling crosstalk. The gene discussed is KRT19; the disease is malignant colon neoplasm.